Alejandra Davidovics Easton is an experienced leader in the biotech and pharmaceutical sectors, currently serving as the Biotech Site Head at Merck Group in Aubonne since January 2015, overseeing a facility of 850 personnel and managing various crucial processes for drug production. Alejandra has held multiple high-level positions throughout a robust career, including Global Head of Business Transformation Unit, Biotech Site Director at Tres Cantos, and Operations Manager, demonstrating expertise in operational excellence and facility transformation. With a strong academic background, including a Master in Bioprocessing Engineering from UCL and specialized training from INSEAD and Stanford University, Alejandra combines technical proficiency in bioprocessing with leadership skills to drive innovation and efficiency within global pharmaceutical operations.